November 23, 2022
The U.S. Food and Drug Administration has approved etranacogene dezaparvovec (EtranaDez), the first gene therapy option for adults with hemophilia B who currently use factor IX prophylaxis therapy, […]
November 22, 2022
The US Food and Drug Administration (FDA) issued an alert today that cited preliminary evidence for a “substantial risk” for severe and symptomatic hypocalcemia and serious […]
November 18, 2022
The US Food and Drug Administration has approved the anti-CD3 monoclonal antibody teplizumab-mzwv (Tzield, Provention Bio) to delay the onset of clinical type 1 diabetes in […]
November 10, 2022
America’s Frontline Doctors is suing one of its founders in a battle for control over the controversial group, which gained national notoriety for spreading misinformation about […]
November 9, 2022
Marijuana use increased significantly during the pandemic in states where it is illegal and in states where medical marijuana is legal, according to a new study. […]
November 4, 2022
The US Food and Drug Administration (FDA) has expanded the indication for tenofovir alafenamide (Vemlidy) to children aged 12 years and older with chronic hepatitis B […]
October 25, 2022
The US Food and Drug Administration (FDA) has granted accelerated approval to teclistamab (Tecvayli, Janssen Biotech, Inc.) for adults with relapsed or refractory multiple myeloma after […]
October 24, 2022
The US Food and Drug Administration (FDA) has approved a new immunotherapy combination for use in the treatment of unresectable hepatocellular carcinoma (HCC), the most common […]
October 24, 2022
The US Food and Drug Administration (FDA) has approved the Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) for adults with nonradiographic axial spondyloarthritis (nr-axSpA) who have objective […]